UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026251
Receipt number R000030153
Scientific Title The effect of Lumbricus rubellus for tinnitus control: randomized double-blind placebo-controlled clinical trial
Date of disclosure of the study information 2017/03/01
Last modified on 2019/02/06 13:54:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of Lumbricus rubellus for tinnitus control: randomized double-blind placebo-controlled clinical trial

Acronym

The effect of Lumbricus rubellus for tinnitus control

Scientific Title

The effect of Lumbricus rubellus for tinnitus control: randomized double-blind placebo-controlled clinical trial

Scientific Title:Acronym

The effect of Lumbricus rubellus for tinnitus control

Region

Japan


Condition

Condition

Bilateral tinnitus in patients with age-associated hearing loss

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To analyze the effect of Lumbricus rebellus on control of bilateral tinnitus in patients with age-associated hearing loss

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Tinnitus Handicap Inventory (THI-25), 4 weeks after medication

Key secondary outcomes

1) Pure Tone Audiometry, Speech Audiometry
2) Pitch match test
3) GTT test(coagulation time,lysis time)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Lumbricus rubellus 600mg per day, 4 weeks

Interventions/Control_2

placebo 4 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients show age-related hearing loss
2) Patients have bilateral tinnitus

Key exclusion criteria

1) Tinnitus derived from inner ear diseases (sudden hearing loss, acoustic tumor, acoustic trauma, otosclerosis)
2) unilateral tinnitus

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Keiji Matsuda

Organization

University of Miyazaki

Division name

Department of Otorhinolaryngology, Head and Neck Surgery

Zip code


Address

5200 Kihara, Kiyotake, Miyazaki city

TEL

0985-85-2966

Email

kmatsuda@med.miyazaki-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Keiji Matsuda

Organization

University of Miyazaki

Division name

Department of Otorhinolaryngology, Head and Neck Surgery

Zip code


Address

5200 Kihara, Kiyotake, Miyazaki city

TEL

0985-85-2966

Homepage URL


Email

kmatsuda@med.miyazaki-u.ac.jp


Sponsor or person

Institute

University of Miyazaki

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

宮崎大学病院(宮崎県)


Other administrative information

Date of disclosure of the study information

2017 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2017 Year 02 Month 21 Day

Date of IRB


Anticipated trial start date

2017 Year 03 Month 15 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry

2020 Year 06 Month 30 Day

Date trial data considered complete

2020 Year 09 Month 30 Day

Date analysis concluded

2020 Year 09 Month 30 Day


Other

Other related information



Management information

Registered date

2017 Year 02 Month 21 Day

Last modified on

2019 Year 02 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030153


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name